Therapeutic strategies for afatinib‐resistant lung cancer harboring HER2 alterations
Sign Up to like & getrecommendations! Published in 2018 at "Cancer Science"
DOI: 10.1111/cas.13571
Abstract: Human epidermal growth factor receptor 2 (HER2) plays an important role in the pathogenesis of various cancers. HER2 alterations have been suggested to be a therapeutic target in non‐small‐cell lung cancer (NSCLC), just as in… read more here.
Keywords: afatinib; resistance; her2 alterations; cancer ... See more keywords